Carregant...
Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines
Background: Low effectiveness of chemotherapy in ovarian cancer results from development of drug resistance during treatment. Topotecan (TOP) is a chemotherapeutic drug used in second-line chemotherapy of this cancer. Unfortunately, during treatment cancer can develop diverse cellular and tissue spe...
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277650/ https://ncbi.nlm.nih.gov/pubmed/30519347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27342 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|